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emic. The last of these is called Swine ﬂue (inﬂuenza A
1N1), which since its inception has caused great alarm,
igh morbidity and mortality especially in pregnant women.
his is a sample of the features of the disease in Dominican
epublic.
Dominican Republic is a tropical country located in
he Caribbean that receive substantial annual number of
ourists, which makes inﬂuenza outbreaks throughout the
ear: both seasonal peaks in the northern and southern
emisphere.
Methods: The Epidemiology National Program starts a
urveillance since the epidemic arise at level 5, at epidemi-
logical week 16.
Diagnosis conﬁrmation was made with rt- PCR for A H1N1
o all symptomatic respiratory cases.
Results: Until the 40th epidemiology week, we have
,664 suspicious cases, 997 (37%) hospitalized, 441 con-
rmed cases, from this 191 (45%) hospitalized, and 22 (5%)
eath, 76 (17%) cases were pregnant women with 16% mor-
ality.
Clinical manifestations were: fever (94%), cough (89%),
asal congestion (76%), headache (71%), muscle pain (67%),
ore throat (60%), dyspnoea (45%), nausea (25%), rales (21%),
omiting (18%) and diarrhoea (11%).
Pregnancy was one of the more important risk factor
ssociated with mortality.
Necropsy ﬁndings where: edema, hemorrhage and necro-
is in lung tissues, frequently associate with intravascular
hrombosis.
High mortality was cause due a delay in search of medi-
al attention and no suspected diagnosis from health cares
ersonel.
Conclusion: It must be increased the Primary Care Ser-
ices to obtain an early diagnosis of the disease, and began
he antiviral treatment in high risk populations, when this
athology is suspected, mostly in pregnant women.
oi:10.1016/j.ijid.2010.02.1711
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Background: Since 1 May to 31 October 2009, 1,241,612
ases of a kind of Inﬂuenza disease were notiﬁed in Argen-
ine. 24,504 virologic samples were processed, conﬁrming
hat 10,248 were cases of AH1N1 Inﬂuenza, there were
2,471 cases that required hospitalization and 600 conﬁrmed
eaths.
Oncohematologic patients were in the high risk group to
his infection. As a preventive strategy a prolonged prophy-
axis with oseltamivir was administered during 30 days.
(
o
iternational Congress on Infectious Diseases (ICID) Abstracts
Our objetive was value the adherence, security and efﬁ-
iency of the prolonged prophylaxis against AH1N1 Inﬂuenza
ith oseltamivir in an oncohematologic patients cohort.
Methods: From July to September 2009, a prospective
tudy was performed from a cohort of 45 oncohematologic
atients above 19 years old, that received a 75mg daily dose
f oseltamivir during 30 days. Then, by an anonymous survey,
ge was consulted, as well as sex, oncohematologic pathol-
gy, treatment performance, adverse effects that patients
resented, doses that were used, whether and why medica-
ion was interrupted, concomitant medication and whether
he patient had to consult the doctor during that period of
ime.
Results: Nor Inﬂuenza Syndromes were registered in the
ohort, neither Inﬂuenza cases during the administration of
uch prophylaxis. Medium age was 54 years (range 19-87), 22
emales and 23 males. Basal diseases were Lymphomas in 42,
% of the cases; Acute Leukemias in 24%; Multiple Myeloma
n 17, 8%; Hodgkin disease in 11,1% and Myelodysplasia in
,7%.
From 45 patients, 24 (53, 3%) presented adverse effects,
0% with digestive symptoms, 18% neurologic and 15%
atigue.
In 34 patients (75, 5%) a 100% adherence was achieved.
rom those patients that did not ﬁnish the treatment, 5
aid that it was because they had a digestive intolerance,
did not give their reasons and another one because he/she
egan late.
No serious adverse effects requiring hospitalization were
bjectived.
There were 32 patients that were already receiving other
edication during antiviral prophylaxis, and only 6 patients
ad to consult their doctor during such period of time.
Conclusion: Daily prophylaxis efﬁciency with oseltamivir
as successful in 100% of the cases. The adherence to
seltamivir was partial (75,5%) mainly because of digestive
ntolerance. No serious adverse effects were detected.
oi:10.1016/j.ijid.2010.02.1712
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Background: Humoral antibody responses, typically mea-
ured by hemagglutination inhibition (HAI) and viral
eutralization, are common measures of immunity to
nﬂuenza virus infection. An antibody titer of greater than
:40 is thought to correlate to around 50% protection to
nfection, while a 4-fold rise in antibody titers between two
imes is evidence of infection during that interval. Infec-
ion from a speciﬁc strain of inﬂuenza can elicit an antibody
esponse against other strains of inﬂuenza, which may cor-
elate with protection.Methods: Subjects presenting with inﬂuenza like illness
ILI) were recruited from general outpatient clinics through-
ut Hong Kong. Those subjects who tested positive for
nﬂuenza by a rapid diagnostic test, and their household
